Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 708,527	$ (68,320,414)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	2,454,661	3,044,531
Amortization of debt issuance costs	1,337,750	8,109,078
Amortization of prepaid share-based compensation	533,851
Impairments of long-lived assets		292,748
Loss on issuance of warrants		46,928,815
Share-based compensation	39,937	(358,937)
Provision for bad debts
Gain on disposal		5,897
Gain on extinguishment of liabilities	(7,427,193)
Gain on forgiveness of earnout	(6,100,000)
Changes in assets and liabilities, net of acquisition:
Accounts receivable	(343,392)	(825,672)
Inventories	(2,223,566)	(1,311,617)
Prepaid expenses and other current assets	(277,105)	1,001,494
Accounts payable	130,476	360,689
Accrued expenses and other current liabilities	4,831,039	4,564,399
Deferred taxes	(82,104)
Discontinued operations	(219,982)	109,910
Net cash used in operating activities	(6,637,101)	(6,399,079)
Cash flows from investing activities:
Purchases of property and equipment – continuing operations	(826)	(3,076)
Purchase of license agreement		(358,763)
Purchases of property and equipment – discontinued operations	(69,272)	(114,311)
Proceeds from sale of assets		181,000
Net cash used in investing activities	(70,098)	(295,150)
Cash flows from financing activities:
Net proceeds from issuance of common stock	2,989,800	14,798
Net borrowings under lines of credit	3,750,000	4,775,000
Net borrowings under convertible notes		3,360,000
Net repayments under notes payable – related parties		(249,507)
Fees paid for financing costs		(664,389)
Repayments under notes payable – related parties		(116,300)
Repayments under convertible notes payable – related parties	(126,250)
Repayments under convertible notes payable	(4,915,000)
Repurchase of warrants from noteholders		(660,000)
Distributions		(97,968)
Net cash provided by financing activities	1,698,550	6,361,634
Net increase in cash and cash equivalents and restricted cash	(5,008,649)	(332,595)
Cash and cash equivalents and restricted cash, beginning of the year	5,247,836	5,580,431
Cash and cash equivalents and restricted cash, end of the year	239,187	5,247,836
Supplemental disclosure of cash flow information:
Cash paid for interest	1,179,351	444,781
Cash paid for income taxes
Convertible shares under notes payable		7,743,333
Issuance of warrants to noteholders and placement agent		4,335,611
Original issue discount		555,000
Accrued placement agent fees for equity placement
Convertible shares under notes payable – related party	99,199
Issuance of common stock to line of credit holders	60,000
Issuance of common stock to vendors for future services	480,250
Issuance of common stock to employees and directors for settlement of liabilities	318,205
Issuance of common stock to vendors for settlement of liabilities	105,693
Issuance of common stock to noteholders for settlement of accrued interest	1,148,000
Issuance of common stock to noteholders for settlement of cash warrant liabilities	206,779
Shares reserved for future issuance of common stock to debt holders for interest 8	713,510
Forgiveness of interest – related parties	3,861,165
Forgiveness of debt – related parties	$ 5,400,000